Earnings Preview — 5182 total
Estrella Immunopharma reports on May 22 after a brutal month for the stock — and the setup heading in is one of persistent price weakness against a borrow market that has quietly loosened. The price tells the clearest…
AEON Biopharma enters its May 21 earnings report under significant pressure, having already delivered a miss just days ago — and the market has not been forgiving. The stock dropped 12% on May 14 after Q1 EPS came in…
LanzaTech Global arrives at its May 20 earnings print having shed 74% of its value in a single month — a collapse so severe that the stock's entire near-term story is now defined by the damage already done rather than…
Mineralys Therapeutics heads into its May 21 first-quarter earnings report with one of the more unusual positioning setups in small-cap biotech: short sellers are covering aggressively while options traders have swung…
C3is Inc. reports today with a lending market that flags extreme short-side conviction — borrow costs have held above 200% annualised for weeks, and the stock has shed nearly half its value in the past month alone. The…
Bitcoin Depot Inc. heads into its May 21 earnings print in the middle of an abrupt unwind — short sellers have retreated and borrow costs have collapsed, yet the stock is still down 42% on the week. The borrow picture…
Cloudastructure Inc. reports Q1 2026 results on May 20 against a backdrop defined less by short-seller pressure and more by a persistent slide in the stock and a months-long pattern of insider selling. The most telling…
BNRG heads into its May 22 results with the cost to borrow its shares tripling in a single month — the sharpest setup signal heading into the print. The borrow market tells the most urgent story. Cost to borrow has…
BLTE heads into tomorrow's Q1 earnings with short sellers building positions aggressively — and a stock that has given back nearly 17% in a month. The sharpest signal heading into the May 20 report is the jump in short…
SUNE heads into its May 22 earnings report with a striking reversal in short-seller conviction — a sharp easing in positioning that contrasts with some of the most violent earnings reactions in the small-cap solar…
DRTS heads into today's earnings print having gained 22% in a single week — while nearly every comparable medical device name fell sharply. That outperformance stands out. The stock closed at $10.36 on May 15, up 32%…
Federal Realty Investment Trust heads into its May 21 earnings release with the most aggressive bullish options tilt seen in months — a sharp contrast to the subdued short interest picture across the rest of the…
Redwire Corporation arrives at its May 20 earnings print on one of the most striking divergences in its recent history: the stock has gained 43% in a month while shorts have barely budged. Short interest — at 13.6% of…
MSCL (Satellos Bioscience Inc.) arrives at its May 20 earnings event carrying one of the more unusual lending-market signatures in recent weeks — and a sharp insider buying pattern that predates the current run. The…
Caris Life Sciences heads into Thursday's earnings print with one strikingly unusual signal: options traders have turned their most bullish in months, even as the stock has been in freefall. The clearest anomaly is the…
SOPA heads into its May 21 earnings print having shed more than half its value in a single week — and short sellers have piled in at a pace that makes the positioning story almost as dramatic as the price action. Short…
Ensysce Biosciences heads into its May 20 earnings report with an unusually charged lending market — the defining feature of its current setup. The borrow story here is striking. Cost to borrow has risen to 122.7%…
Xponential Fitness heads into Wednesday's Q1 print having lost a third of its value over the past month — and short sellers are pressing harder. Short positioning is the defining story ahead of this release. Short…
CuriosityStream heads into Wednesday's Q2 update carrying fresh wounds from a punishing May earnings reaction, with investors now weighing whether the AI licensing story can survive lumpy revenue delivery. The stock…
LRMR heads into its Q1 2026 earnings today having shed more than a quarter of its value in a month — and short sellers have been adding to their positions throughout the slide. Bears have been busy. Short interest…
